---
figid: PMC10372243__gr1
pmcid: PMC10372243
image_filename: gr1.jpg
figure_link: /pmc/articles/PMC10372243/figure/fig1/
number: Fig. 1
figure_title: ''
caption: Oridonin's effects on the proliferation of 4T1,MCF-7 and MDAMB-231 cells.
  A. 4T1 cell survival rates. B. MCF-7 cell survival rates. C. MDAMB-231 cell survival
  rates.
article_title: Oridonin impedes breast cancer growth by blocking cells in S phase
  and inhibiting the PI3K/AKT/mTOR signaling pathway.
citation: Weijie Zhang, et al. Heliyon. 2023 Jul;9(7):e18046.
year: '2023'

doi: 10.1016/j.heliyon.2023.e18046
journal_title: Heliyon
journal_nlm_ta: Heliyon
publisher_name: Elsevier

keywords:
- Oridonin
- Breast cancer
- Metabolomics
- Amino acid metabolism
- PI3K/AKT/mTOR signaling pathway

---
